Alvarez A, Rodger J, Brosio C et al (2002) Neoadjuvant chemotherapy for stage III breast cancer: Does the addition of paclitaxel to doxorubicin increase complete response-A single institution non-randomized study. Eur J Cancer.38:S73Alvarez A, Rodger J, Brosio C et al. Neoadjuvant chemotherapy...
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: data from the NEOZOTAC trial (BOOG ... A Charehbili,NAT Hamdy,VTHBM Smit,... - 《Breast》 被引量: 5发表: 2016年 Second line neoadjuvant chemotherapy in stage III breast ...
文档标签: Neoadjuvant chemotherapy for breast cancer Chapter3 NeoadjuvantChemotherapyforBreastCancer SuthineeIthimakinandSuebwongChuthapisith Additionalinformationisavailableattheendofthechapter http://dx.doi/10.5772/53124 1.Introduction 1.1.Rationaleofneoadjuvantchemotherapyintreatmentofbreastcancer Neoadjuvantchemother...
Objective To evaluate the efficacy of the neoadjuvant chemotherapy(NACT) for operable stage Ⅲ breast cancer.Methods 74 patients with operable stage Ⅲ breast cancer were randomly assigned to receive either NACT(group A,n=36) or not(group B,n=38).The group A received a short-term NACT with...
I recall what Ina told me after she went to consult the oncologist for her problems. Ina said something to this effect: The doctor was surprised. He said: You have stage 4 cancer and you can walk into my office like a normal person! Generally, stage 4 patient come in a wheelchair look...
Adjuvant chemotherapy for early stage breast cancer The EBCTCG overview of 60 trials of prolonged polychemotherapyvsno chemotherapy involving 36 000 women has confirmed that, adjuvant anthracycline-based chemotherapy reduces the annual odds of death by 38% (s.e.=5), for women under 50 years of...
One hundred seventy-four evaluable patients with noninflammatory Stage III (both operable and inoperable) breast cancer were treated with a combined modality strategy between 1974 and 1985. All patients received combination chemotherapy with 5-fluorouracil, Adriamycin (doxorubicin), and cyclophosphamide (FA...
surgery, chemotherapy, radiation,hormonal therapy, andtargeted therapy[6]. Chemotherapy is still a very important treatment in breast cancer [2,6]. Neoadjuvant chemotherapy has become standard in managinglocally advanced breast cancerand is a treatment choice in early-stage operable breast cancer [7]...
Over the last few decades neoadjuvant chemotherapy (NACT) has been increasingly adopted for breast cancer (BC) patients, along with the introduction of multidisciplinary approaches and the use of targeted therapies and tailored drug regimens [[1],[2],[3]]. ...
Anemia in stage II and III breast cancer patients treated with adjuvant doxorubicin and cyclophosphamide chemotherapy. Oncologist 2004; 9: 25-32KIRSHNER, J.; HATCH, M.; HENNESSY, D. D.; FRIDMAN, M.; TANNOUS, R.E. Anemia in stage II and III breast cancer patients treated with adjuvant ...